Long Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) raised about $38 million on May 1st at $9.00 a share, but given the weak market and the “show me” launch of … Continue Reading
Read now- Eli Lilly and Co. (NYSE: LLY) announced on Friday that it met the FDA’s pediatric exclusivity requirements for Cymbalta, the company’s treatment for depression and … Continue Reading
Read now- Alexza Pharmaceuticals (NASDAQ: ALXA) announced after the market close on Thursday that the FDA has accepted the company’s [resubmitted] ADASUVE New Drug Application (NDA) with … Continue Reading
Read now- A combination of a technical rebound and creative tail-wagging by a SeekingAlpha columnist, writing under the pseudonym ‘Trade In Mexico’, sends shares of Chelsea Therapeutics … Continue Reading
Read now- Rexahn Pharmaceuticals (NYSE Amex: RXX) is trading higher for the fourth consecutive session, with volume at about par to that of the entire month of … Continue Reading
Read now- Sucampo Pharmaceuticals (SCMP) said on Friday that the International Court of Arbitration, International Chamber of Commerce (ICC) did not agree with its claims against partner, … Continue Reading
Read nowLong Ideas - With the FDA action date (PDUFA date) set for July 26th, many investors are focusing on the potential approval of Amarin’s (NASDAQ: AMRN) drug to … Continue Reading
Read now